Roche Pays $4.3 Billion for Spark Therapeutics

28.02.2019 - Swiss drugs giant Roche has agreed to pay $4.3 billion for Spark Therapeutics, marking the latest purchase of a biotech company by big pharma. The deal gives Roche the first US...